These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8099651)

  • 1. Torsades de pointes and proarrhythmia.
    Ben-David J; Zipes DP
    Lancet; 1993 Jun; 341(8860):1578-82. PubMed ID: 8099651
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of drug-induced arrhythmias.
    Vos MA; Paulussen AD
    Ann Med; 2004; 36 Suppl 1():35-40. PubMed ID: 15176422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long QT syndrome: when syncope is common to the young and the elderly.
    Futterman LG; Lemberg L
    Am J Crit Care; 1995 Sep; 4(5):405-12. PubMed ID: 7489046
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding drug-induced torsades de pointes: a genetic stance.
    Kannankeril PJ
    Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs, QT interval abnormalities and ventricular arrhythmias.
    Thomas SH
    Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900
    [No Abstract]   [Full Text] [Related]  

  • 8. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modulation of cardiac repolarization reserve.
    Remme CA; Bezzina CR
    Heart Rhythm; 2007 May; 4(5):608-10. PubMed ID: 17467629
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced torsades de pointes and implications for drug development.
    Fenichel RR; Malik M; Antzelevitch C; Sanguinetti M; Roden DM; Priori SG; Ruskin JN; Lipicky RJ; Cantilena LR;
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):475-95. PubMed ID: 15090000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
    Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
    Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in repolarization dynamicity and the assessment of the arrhythmic risk.
    Maison-Blanche P; Coumel P
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2614-24. PubMed ID: 9358509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired long QT syndromes and the risk of proarrhythmia.
    Roden DM
    J Cardiovasc Electrophysiol; 2000 Aug; 11(8):938-40. PubMed ID: 10969760
    [No Abstract]   [Full Text] [Related]  

  • 18. Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
    Saussine M; Massad I; Raczka F; Davy JM; Frapier JM
    Paediatr Anaesth; 2006 Jan; 16(1):63-5. PubMed ID: 16409532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular basis of drug-induced torsades de pointes.
    Roden DM
    Br J Pharmacol; 2008 Aug; 154(7):1502-7. PubMed ID: 18552874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.